1340480-93-4 Usage
General Description
The chemical "(R)-4-((S)-2-((E)-3-(4-chlorophenyl)acrylaMido)propanaMido)-N1-((S)-1,6-diaMino-1-oxohexan-2-yl)pentanediaMide" is a complex compound containing a number of functional groups. It consists of two amide groups, a 4-chlorophenyl group, and a hexan-2-yl pentanediMide group. The compound is asymmetric in nature, with both R and S configurations at different positions. It is likely to have biological activity due to the presence of the chlorophenyl group and the amide functionalities, making it potentially useful in pharmaceutical research as a potential drug candidate. Additionally, the compound's structure suggests that it may have the ability to bind to other molecules, making it useful for further investigation in drug design and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1340480-93-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,0,4,8 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1340480-93:
(9*1)+(8*3)+(7*4)+(6*0)+(5*4)+(4*8)+(3*0)+(2*9)+(1*3)=134
134 % 10 = 4
So 1340480-93-4 is a valid CAS Registry Number.
1340480-93-4Relevant articles and documents
CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE
-
, (2017/10/24)
The present invention discloses chemical synthesis, anti-tumor and anti-metastatic effects of a dual functional conjugate as showed by formula I. In detail, paclitaxel or docetaxol is linked with muramyl dipeptide derivative to form a conjugate, thus dual anti-tumor and anti-metastatic effects are achieved by combination of chemotherapy and immunotherapy. The present invention also discloses that paclitaxel or docetaxol and muramyl dipeptide derivative conjugate is synthesized by combination of solid-phase and solution-phase synthesis, and said conjugate can be used in manufacture of anti-tumor medicaments as proved by reliable bioassays.
Conjugate (MTC-220) of muramyl dipeptide analogue and paclitaxel prevents both tumor growth and metastasis in mice
Ma, Yao,Zhao, Nan,Liu, Gang
experimental part, p. 2767 - 2777 (2011/06/23)
1 (MTC-220), a conjugate of paclitaxel and a muramyl dipeptide analogue, has been synthesized as a novel agent of dual antitumor growth and metastasis activities. In vitro and in vivo tests show that 1 retains its ability to inhibit tumor growth. It is su
